{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:33:55Z","timestamp":1761885235636,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.acuroe.2020.06.004","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T13:46:43Z","timestamp":1623851203000},"page":"455-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma"],"prefix":"10.1016","volume":"45","author":[{"given":"J.M.","family":"Abascal-Junquera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fumad\u00f3-Ciutat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gasa-Galmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Costa-Planells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Munarriz-Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sanrom\u00e0-Salv\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Polaina-Barroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sol\u00e0-Marqu\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Juanpere-Rodero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lloreta-Trull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cecchini-Rosell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2020.06.004_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0010","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.urology.2009.07.1360","article-title":"Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the surveillance, epidemiology, and end results program","volume":"75","author":"Cetin","year":"2010","journal-title":"Urology."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.acuro.2012.06.006","article-title":"Registro Nacional de c\u00e1ncer de pr\u00f3stata 2010 en Espa\u00f1a","volume":"37","author":"C\u00f3zar","year":"2013","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0025","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0030","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO;2-B","article-title":"Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression","volume":"43","author":"Cohen","year":"2000","journal-title":"Prostate."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.juro.2010.06.017","article-title":"Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings","volume":"184","author":"Robinson","year":"2010","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y","article-title":"Ductal spread in prostatic carcinoma","volume":"56","author":"Kovi","year":"1985","journal-title":"Cancer."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/PAS.0b013e3181cfc44b","article-title":"Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies","volume":"34","author":"Shah","year":"2010","journal-title":"Am J Surg Path."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/1097-0045(20000901)44:4<265::AID-PROS1>3.0.CO;2-I","article-title":"Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression","volume":"44","author":"Dawkins","year":"2000","journal-title":"Prostate."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/pros.22786","article-title":"Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens","volume":"74","author":"Kimura","year":"2014","journal-title":"Prostate."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Contemporary role of androgen deprivation therapy for prostate cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0070","unstructured":"Mottet N. EAU guidelines on prostate cancer 2020. http:\/\/uroweb.org\/wp-content\/uploads\/EAU-Guidelines-Prostate-Cancer-2020.pdf."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0075","article-title":"The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.eururo.2014.07.020","article-title":"Impact of the site of metastases on survival in patients with metastatic prostate cancer","volume":"68","author":"Gandaglia","year":"2015","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0085","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","article-title":"Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations","volume":"20","author":"McNeal","year":"1996","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.eururo.2017.03.013","article-title":"Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories","volume":"72","author":"Porter","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0110","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/pros.23326","article-title":"Intraductal carcinoma of the prostate on diagnostic needle biopsy predicts prostate cancer mortality: a population-based study","volume":"77","author":"Saeter","year":"2017","journal-title":"Prostate."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.urolonc.2017.08.015","article-title":"Population-based study of the incidence and survival for intraductal carcinoma of the prostate","volume":"35","author":"Dinerman","year":"2017","journal-title":"Urol Oncol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/pros.22906","article-title":"Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?","volume":"75","author":"Zhao","year":"2015","journal-title":"Prostate."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0125","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/pros.23005","article-title":"The presence and clinical implication of intraductal carcinoma of the prostate in CPRC patients","volume":"75","author":"Chen","year":"2015","journal-title":"Prostate."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0130","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.6_suppl.e601","article-title":"Effect of chemotherapy on survival for intraductal carcinoma of the prostate (IDC-P) in patients with castration-resistant prostate cancer","volume":"35","author":"Yamamoto","year":"2017","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.acuroe.2020.06.004_bib0140","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N Engl J Med."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578621000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578621000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:13:57Z","timestamp":1761880437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578621000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2173578621000706"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2020.06.004","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2020.06.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}